Displaying 76–100 of 251 results for Paul Thomas, Senior Editor

Sort By Relevance Sort By Date
1... 2 3 4 5 6 ...11

Roche’s Deutschmann: When Alternative is not Alternative

(Article)

The veteran microbiologist discussed experimentation with a rapid microbiological CFU counting technique, and maintained that validation should not be significantly different than with traditional methods.

Buzz Cue: How is Pharma Gauging Its Greenness?

(Article)

A green chemistry and environmental expert talks about whether pharma is really as green as it thinks it is.

Green Gets Granular: Single-Use vs. Traditional Biopharm Process Trains

(Article)

Process modeling and life cycle assessment are helping to gauge the environmental impact of single-use equipment.

Prioritizing Pharma’s Green Engineering Needs

(Article)

Continuous processing and bioprocesses deserve more attention, says GSK’s Conchita Jimenez-Gonzalez, who chairs the ACS GCI Pharma Roundtable.

PharmaView: What’s Your Saving Story?

(Article)

There’s nothing like a good tale of frugality to make your day.

Who Owns Your Data?

(Article)

IT, Engineering, Lab? The answer under a consolidated system should be no one and everyone, says Patni’s Jim Macdonell.

Abbott: Building a Stable Foundation for Continuous Improvement

(Article)

Abbott's Continuous Improvement Manager shares best practices on how to prepare an organization for Lean and Six Sigma projects.

PharmaView: Should Pharma Fear the Supply Chain of the Future?

(Article)

As paradigms shift, we also need paradigm expansion.

2011: Progress on the Pedigree Front?

(Article)

Maxiom Group’s Scott Dicks answers our questions about whether drug manufacturers are moving ahead with electronic pedigree programs, software

Can Drug Manufacturers Find Business Benefits in Product Serialization?

(Article)

John Danese, Oracle’s Director of Product Strategy, provides an update on the electronic pedigree landscape and how manufacturers are doing in their serialization efforts.

Pedigree Adopters Play the Waiting Game

(Article)

Manufacturers’ electronic pedigree and serialization efforts creep ahead, slowed by FDA’s inaction.

Onsite and Online, Interphex Attracting Visitors

(Article)

The annual spring tradeshow has reenergized itself by building a year-round online presence.

Controlled Ice Nucleation Moves into Manufacturing

(Article)

Two viable techniques exist for better lyo control in commercial processes, says UConn’s freeze-drying guru.

PharmaView: Pharma Job Cuts: Decisive, Long-term Strategic Actions?

(Article)

There’s no good way to deliver bad news, but that doesn’t mean it should be hidden or glossed over.

On the Brink of Burnout

(Article)

Our annual survey results say you’ve just about had enough. Will 2011 be the year things turn in your favor?

Pharma Jobs 2011: Curb Your Enthusiasm, and Ego

(Article)

There’s still not enough evidence for full-fledged optimism, says a leading recruiter.

PharmaView: CEOs: Head Cases?

(Article)

For CEOs, maybe therapy comes with the territory.

Production Planning Amid Uncertainty

(Article)

Production planning is hard enough, but when uncertainty peaks, the challenges are compounded.

Can Personalized Medicine Be Automated, and Accelerated?

(Article)

Customized, cheaper immunotherapies could be delivered to patients within a month, says Argos Therapeutics’ head of manufacturing.

Critical Parameters of Managing Contract Risks

(Article)

Three experts share their views and best practices of risk-based contract partnerships.

PharmaView: Pharma M&As: Been There, Done That?

(Article)

If the “serial acquirers” don’t kill us, they’ll make us stronger.

Merck's Silverman: Time to Upgrade Regs for Environmental Risk Assessments

(Article)

In searching for a model, FDA and EMA need look no further than Canada.

Particles in Parenterals: Regulatory and Compendial Considerations

(Article)

Pfizer’s John Shabushnig shares insights into burning compendial and regulatory issues.

Japan's PMDA Seeks Harmony with China, Korea, and Beyond

(Article)

Win-win aspects must guide any international collaborations, says Japan’s Toshiyoshi Tominaga.

Sort By Relevance Sort By Date
1... 2 3 4 5 6 ...11